A Rare COVID-19 Presentation, Relapse of Nephrotic Syndrome in a Pediatric Patient
Erciyes Medical Journal
; 45(1):104-105, 2023.
Article
in English
| EMBASE | ID: covidwho-2228654
ABSTRACT
Background:
In early 2020, severe acute respiratory syndrome-corona virus 2 (SARS-CoV-2) pandemics caused previously unheard of health, social, and economic problems worldwide. The disease can affect different organs such as the lungs, heart, pancreas, kidney, and unusual symptoms can be seen. Information on the clinical impact of SARS-CoV-2 infection on renal function among pediatric age groups is scarce. Case Report In this report, we presented a 13-year-old boy who was admitted to our hospital with the relapse of nephrotic syndrome caused by COVID-19. The patient had mild upper respiratory tract symptoms, eyelid edema and progressive swelling of the lower extremities. Clinical remission was achieved with oral prednisolone therapy without the use of any antiviral drugs. Conclusion(s) Patients with nephrotic syndrome presenting with relapse should be evaluated for potential COVID-19 infection during the pandemic. The use of routine doses of prednisolone appears to be safe in mild disease. Copyright © 2023 by Erciyes University Faculty of Medicine.
children; covid-19; immunosuppression; nephrotic syndrome; proteinuria; relapse; abdominal tenderness; absolute lymphocyte count; adolescent; article; case report; clinical article; coronavirus disease 2019; drug dose reduction; edema; eyelid edema; fatigue; human; immunosuppressive treatment; leg swelling; leukocyte count; lymphocytopenia; male; nephrotic syndrome/di [Diagnosis]; nephrotic syndrome/dt [Drug Therapy]; nose obstruction; pediatric patient; periorbital edema; platelet count; protein creatinine ratio; pulse oximetry; relapse/di [Diagnosis]; reverse transcription polymerase chain reaction; upper respiratory tract infection; urea nitrogen blood level; urinalysis; albumin/ec [Endogenous Compound]; bicarbonate/ec [Endogenous Compound]; chloride/ec [Endogenous Compound]; creatinine/ec [Endogenous Compound]; hemoglobin/ec [Endogenous Compound]; lactic acid/ec [Endogenous Compound]; potassium/ec [Endogenous Compound]; prednisolone/dt [Drug Therapy]; prednisolone/po [Oral Drug Administration]; prednisolone/pv [Special Situation for Pharmacovigilance]; sodium/ec [Endogenous Compound]; pretibial edema
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Experimental Studies
/
Prognostic study
/
Randomized controlled trials
Language:
English
Journal:
Erciyes Medical Journal
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS